Australia Gummy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The Australia gummy market size was USD 356.72 million in 2026 and is forecast to reach USD 763.28 million by 2031, growing at a CAGR of 8.24% from 2026 to 2031. This report is segmented by Product Type (Single-Vitamin, Multivitamin, Probiotic, Omega-3, Collagen, and Others), Source (Animal-Based and Plant-Based), Consumer Group (Children and Adults), Packaging (Bottles and Jars, Stand-Up Pouches, and Others), and Distribution Channel (Supermarkets, Pharmacy/Drug Stores, Online Retail, and Others). The Market Forecasts are Provided in Terms of Value (USD).

Australia Gummy Market Trends and Insights

Growing Consumer Interest in Convenient Nutritional Supplements

The Australia gummy market is supported by a shift from occasional supplement purchases toward daily habits. Gummies reduce swallowing and taste barriers that can limit use of standard supplements. This feature is relevant for adults aged 65 and above, a group that benefits from simpler daily routines. The wider complementary medicines sector reached AUD 6.30 billion, equivalent to USD 4.0 billion, in 2025 and is expected to grow by 3.0% to 4.0% annually through 2030. Gummy products are growing faster than that sector because they fit both routine use and casual wellness purchasing. Demand is strongest in large metropolitan areas, where supermarket, pharmacy, and online availability make product trial easier. Swisse Wellness used its “Functional. Fun. Gummies.” campaign and a “Sweet Treat” creative chapter in 2026 to promote the format across pharmacy and supermarket settings. The campaign shows how branded format education can increase product trial and repeat purchase. Wider access to easy-to-consume products also supports adults who may avoid large tablets or fish-oil softgels. This affects the Australia gummy market because a pleasant format may strengthen adherence after the first purchase. Products designed for convenience can therefore achieve repeat demand without relying only on changes in core ingredients. The same preference supports alternative dosage forms among younger adults and older consumers, who have different needs but share a preference for straightforward consumption.

Rising Demand for Vitamins and Mineral Gummies Among Adults

Adult buyers increasingly use supplements for energy, immune support, beauty, sleep, cognitive support, and other wellness needs. A single product can combine nutritional ingredients with beauty or condition-related positioning. This reduces the need for separate purchases and supports premium price points. Nature’s Way registered Collagen Beauty Complex in October 2024 and Adult Vita Gummies Omega-3 in June 2025 on the Australian Register of Therapeutic Goods. These registrations show the use of targeted adult products across more than one health need. Adult formats can generate higher returns for brands and retailers when they combine specialized ingredients with clear product positioning. Premium products often use collagen, magnesium, Omega-3, or multiple ingredients to address a defined use case. The Australia gummy market benefits when these products encourage consumers to move beyond basic multivitamins. New products also give pharmacy retailers a reason to refresh shelf space and feature differentiated ranges. Adult growth supports a broader move toward targeted gummies, including products for women’s health, sleep, and brain health. The resulting product range makes the format relevant across more stages of adult life.

Strict Regulatory Requirements for Therapeutic Gummy Products

The Australia gummy market operates within rules for listed medicines when products make relevant health-related claims. The Therapeutic Goods Act 1989 sets requirements for ingredients, manufacturing quality, and labeling. Compliance adds time and cost for companies developing new products. Complementary Medicines Australia counted 81.00 TGA-licensed complementary medicine manufacturing facilities in 2025, while only a limited number were equipped for gummy production. This limits contract-manufacturing options for brands that do not own licensed facilities. Small businesses and new concepts can be affected most because they may lack the resources to manage certification and compliance work. Star Combo Pharma reported TGA manufacturing approval for its gummy facility in May 2024, identifying it as a large-scale licensed gummy contract manufacturer in Australia. The facility shows why manufacturing approvals can create a meaningful barrier to entry. The Permissible Ingredients Determination was updated in March 2025, with a 12-month transition period ending in March 2026. Companies need continued regulatory monitoring when they use ingredients in listed products. Health claim and advertising rules also reduce how directly brands can explain a product’s clinical rationale. These limits can make customer education more difficult, especially for new functional gummies that need clear communication.

Other drivers and restraints analyzed in the detailed report include:

• Increasing Popularity of Children’s Vitamin and Supplement Gummies
• Functional and Condition-Specific Gummies
• High Sugar Content in Conventional Gummy Formulations

Segment Analysis

Omega-3 gummies are forecast to expand at a 9.66% CAGR through 2031. The format gives consumers an alternative to fish-oil softgels, which some find difficult to swallow or unpleasant to taste. Demand relates to interest in cardiovascular, cognitive, and joint health uses. Nature’s Way Adult Vita Gummies Omega-3 was listed on the ARTG in June 2025 under ID 490672. This listing supported the company’s broader move into specialty gummy products. Vegan and algae-derived Omega-3 options also appeal to consumers seeking plant-based products or alternatives to fish-derived ingredients. Probiotic gummies have different technical needs because manufacturers must protect shelf-stable probiotic systems and manage higher ingredient loads.

Multivitamin gummies commanded 38.21% of the Australia gummy market share in 2025, making them the core revenue category. They are often the first gummy product used by consumers across age groups. Single-vitamin products meet more targeted needs, including Vitamin D, Vitamin C, biotin, and iron. These formats can benefit from recommendations by health professionals, which can support product trial. Their broad availability also gives pharmacies and supermarkets a familiar base range. Multivitamins are likely to remain important even as specialty products expand because they serve everyday routine use.

Animal-based gummies held 57.46% of the Australia gummy market share in 2025. Gelatin supports this position because it is relatively cost-efficient, easy to work with, and familiar to consumers. Brands continue to use animal-derived formats for mainstream products where price and texture consistency matter. Premium animal-derived products are increasingly differentiated through ingredient sourcing and bioavailability rather than price. This creates a range of positions within the same source category. Consumer familiarity also supports continued shelf presence for gelatin-based multivitamin and single-vitamin products.

Plant-based gummies are forecast to grow at a 9.78% CAGR through 2031. Their growth is linked to vegan preferences, clean-label purchasing, and interest in sustainability-related product choices. Pectin and algae-based matrices fit this positioning. Vegan certification can make dietary compatibility easier to identify for shoppers who have not chosen a brand before entering a pharmacy. This visual signal matters in stores where consumers compare several products. The Australia gummy market has room for plant-based products where companies can make their value clear without making unsupported claims.

Complete Report Scope:

• By Product Type
  • Single-Vitamin
  • Multivitamin
  • Probiotic
  • Omega-3
  • Collagen
  • Other Gummies
• By Source
  • Animal-Based
  • Plant-Based
• By Consumer Group
  • Children
  • Adults
• By Packaging Type
  • Bottles and Jars
  • Stand-up Pouches
  • Others
• By Distribution Channels
  • Supermarkets/Hypermarkets
  • Pharmacy/Drug Stores
  • Online Retail Stores
  • Other Distribution Channels

List of Companies Covered in this Report:

• Swisse Wellness Pty Ltd
• PharmaCare Laboratories Pty Ltd
• Blackmores Limited
• Bayer AG
• Herbaland Naturals Inc.
• Amway Corporation
• The Nature's Bounty Co.
• Garden of Life LLC
• Church & Dwight Co., Inc.
• Perrigo Company plc
• CannazALL
• Haleon plc
• Nestlé Health Science
• Star Combo Pharma Limited
• BioCeuticals Pty Ltd
• Fusion Health Australia Pty Ltd
• Eagle Health Holdings Limited
• Haircare Bear
• Ultralife
• HealthCareBear

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support